EndocrinologyPeer Reviewed

Cytologically non-malignant thyroid nodules with three or more high-risk genetic mutations have poor outcomes.

Authors (7)
Alexander R GoldbergHolman Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Cheng LiuDepartment of Pathology, NYU Grossman School of Medicine, New York, New York, USA.
Gary D RothbergerHolman Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Kepal N PatelDivision of Endocrine Surgery, Department of Surgery, NYU Grossman School of Medicine, New York, New York, USA.
Endocrine oncology (Bristol, England)
Unknown
Published
Oct 13, 2025
View Original

Abstract

Abstract not available - data parsing issue resolved

Keywords

EIF1AX mutationRAS mutationTERT mutationcytologythyroid cancerthyroid genetics

Article Metrics

Sourcepubmed

Related Research

Explore more articles in this research category to discover related studies and findings.

View more in Endocrinology